- Home
- THAR vs AMST Comparison
THAR vs AMST Comparison
Compare THAR & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- AMST
- Stock Information
- Founded
- THAR 2017
- AMST 2017
- Country
- THAR United States
- AMST United States
- Employees
- THAR N/A
- AMST N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- THAR Health Care
- AMST Technology
- Exchange
- THAR Nasdaq
- AMST Nasdaq
- Market Cap
- THAR 16.8M
- AMST 14.0M
- IPO Year
- THAR 2022
- AMST 2020
- Fundamental
- Price
- THAR $3.16
- AMST $3.28
- Analyst Decision
- THAR Strong Buy
- AMST
- Analyst Count
- THAR 1
- AMST 0
- Target Price
- THAR $17.00
- AMST N/A
- AVG Volume (30 Days)
- THAR 556.4K
- AMST 59.8K
- Earning Date
- THAR 11-06-2025
- AMST 11-13-2025
- Dividend Yield
- THAR N/A
- AMST N/A
- EPS Growth
- THAR N/A
- AMST N/A
- EPS
- THAR N/A
- AMST N/A
- Revenue
- THAR N/A
- AMST $110,459.00
- Revenue This Year
- THAR N/A
- AMST N/A
- Revenue Next Year
- THAR N/A
- AMST N/A
- P/E Ratio
- THAR N/A
- AMST N/A
- Revenue Growth
- THAR N/A
- AMST N/A
- 52 Week Low
- THAR $0.95
- AMST $2.00
- 52 Week High
- THAR $9.08
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- THAR 51.38
- AMST 51.57
- Support Level
- THAR $2.79
- AMST $3.37
- Resistance Level
- THAR $3.52
- AMST $3.60
- Average True Range (ATR)
- THAR 0.25
- AMST 0.19
- MACD
- THAR 0.02
- AMST 0.00
- Stochastic Oscillator
- THAR 51.02
- AMST 53.03
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.